2-Substituted 1-azabicycloalkanes, a new class of non-opiate antinociceptive agents. 1992

J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
Drug Discovery Research, R.W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania 19477-0776.

2-Substituted 1-azabicycloalkanes (3- and 5-aryloctahydroindolizines 2 and 11, 3-cyclohexyloctahydroindolizine 12, 4-aryloctahydroquinolizines 13, and 3-arylhexahydropyrrolizines 14) constitute a new class of non-opiate antinociceptive agents. These compounds demonstrated activity in the mouse abdominal constriction test and many were active in the mouse tail-flick test. trans-3-(2-Bromophenyl)octahydroindolizine (2a) did not bind to the opiate receptor nor did it affect arachidonate metabolism. 3-Aryloctahydroindolizines were prepared by catalytic hydrogenation of 1-aryl-3-(2-pyridinyl)-2-propen-1-ones. The X-ray crystal structure of (-)-2a was determined and absolute stereochemistry assigned as 3-R,8a-R.

UI MeSH Term Description Entries
D007212 Indolizines
D011763 Pyrrolizidine Alkaloids A group of ALKALOIDS, characterized by a nitrogen-containing necine, occurring mainly in plants of the BORAGINACEAE; COMPOSITAE; and LEGUMINOSAE plant families. They can be activated in the liver by hydrolysis of the ester and desaturation of the necine base to reactive electrophilic pyrrolic CYTOTOXINS. Pyrrolizidine Alkaloid,Senecio Alkaloid,Senecio Alkaloids,Alkaloid, Pyrrolizidine,Alkaloid, Senecio,Alkaloids, Pyrrolizidine,Alkaloids, Senecio
D011807 Quinolizines
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014961 X-Ray Diffraction The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Xray Diffraction,Diffraction, X-Ray,Diffraction, Xray,Diffractions, X-Ray,Diffractions, Xray,X Ray Diffraction,X-Ray Diffractions,Xray Diffractions
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
April 1995, Journal of medicinal chemistry,
J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
June 2004, Bioorganic & medicinal chemistry letters,
J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
July 1961, Journal of medicinal and pharmaceutical chemistry,
J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
November 1982, Journal of pharmaceutical sciences,
J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
September 1968, Journal of medicinal chemistry,
J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
May 1970, Journal of medicinal chemistry,
J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
October 1975, Arzneimittel-Forschung,
J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
July 1979, Journal of medicinal chemistry,
J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
August 1992, Journal of medicinal chemistry,
J R Carson, and R J Carmosin, and J L Vaught, and J F Gardocki, and M J Costanzo, and R B Raffa, and H R Almond
September 2004, European journal of medicinal chemistry,
Copied contents to your clipboard!